Caribou Biosciences (CRBU) Shares Fall 35% After Hours: Here's Why
Caribou Biosciences shares fall 35% after hours as the company weighs strategic alternatives and cuts two drug programs.
Share
Why It Matters
Caribou stopped working on two medicines and is looking at big changes. When a company cuts programs, people wonder if the business plan is working.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.